Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening
Scanlon P H, Aldington S J, Leal J, Luengo-Fernandez R, Oke J, Sivaprasad S, Gazis A, Stratton I M
            Record ID 32012000329
            English
                                    
                Authors' objectives:
                To determine whether personalised screening intervals are cost-effective.
            
                                                
                Authors' recommendations:
                The study found that annual screening of all patients for STDR was not cost-effective. Screening this entire cohort every 3 years was most likely to be cost-effective. When personalised intervals are applied, screening those in our low-risk groups every 5 years was found to be cost-effective. Screening high-risk groups every 2 years further improved the cost-effectiveness of the programme. There was considerable uncertainty in the estimated incremental costs and in the incremental QALYs, particularly with regard to implications of an increasing proportion of maculopathy cases receiving intravitreal injection rather than laser treatment. Future work should focus on improving the understanding of risk, validating in further populations and investigating quality issues in imaging and assessment including the potential for automated image grading.
            
                                    
            Details
                        
                Project Status:
                Completed
            
                                    
                URL for project:
                http://www.nets.nihr.ac.uk/projects/hta/106601
            
                                                
                Year Published:
                2015
            
                                    
                URL for published report:
                http://www.journalslibrary.nihr.ac.uk/hta/hta19740/#/abstract
            
                                                            
                English language abstract:
                An English language summary is available
            
                                    
                Publication Type:
                Not Assigned
            
                                    
                Country:
                England, United Kingdom
            
                                                
                        MeSH Terms
            - Diabetic Retinopathy
- Mass Screening
- Costs and Cost Analysis
Contact
                        
                Organisation Name:
                NIHR Health Technology Assessment programme
            
            
                        
                Contact Address:
                NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
            
                                    
                Contact Name:
                journals.library@nihr.ac.uk
            
                                    
                Contact Email:
                journals.library@nihr.ac.uk
            
                                    
                Copyright:
                Queen's Printer and Controller of HMSO
            
                    
                This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.